Shares of Jubilant Life Sciences skid as much as 6.8 per cent to hit a low of Rs 773 on the BSE on Monday after the company's June quarter profit more-than-halved to Rs 88 crore.
The pharmaceutical firm's consolidated net profit came in at Rs 88.01 crore, down 52.42 per cent from Rs 184.98 crore reported in the year-ago period. Consolidated total revenue from the operations stood at Rs 1,892.92 crore for the quarter under review, as against Rs 2,181.86 crore for the same period a year ago.
"Overall, barring unforeseen circumstances, we expect strong performance in our Pharma, Life Science Ingredients